Correction: Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study
Yan Wu(Tongji University), Qiuning Sun(Anhui Medical University), Lai Wei(Sun Yat-sen University), Xiaowen Pang(Air Force General Hospital PLA), Philippe Picaut(Ipsen (France)), Bill Andriopoulos, Chengxin Li(Huazhong University of Science and Technology), Li Li(Sichuan University), Fang Fang(Jinshan Hospital of Fudan University), Quanzhong Liu(Tianjin Medical University General Hospital), Jianyun Lu(Central South University), Inna Prygova, Xiaofeng Shi, Jiaming Sun(Wuhan Union Hospital)
Cited by 0
Related Papers
Telomere Length and All-Cause Mortality: A Meta-analysis
|Ageing Research Reviews|2018|332
Global Aesthetics Consensus: Avoidance and Management of Complications from Hyaluronic Acid Fillers—Evidence- and Opinion-Based Review and Consensus Recommendations
|Plastic & Reconstructive Surgery|2016|326
Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
|Journal of Clinical Oncology|2009|245
Flexible polystyrene/graphene composites with epsilon-near-zero properties
|Advanced Composites and Hybrid Materials|2022|223